Becton, Dickinson and Company
BDX Healthcare Medical Instruments & Supplies
In the quarter to June 2026, revenue grew 5.44%, EPS fell 31.5%, free cash flow fell 31.6% and total debt fell 22.9%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for three.
Follow BDX
Becton, Dickinson and Company (BDX) Net income
Becton, Dickinson and Company's net income for fiscal 2025 was $1.7B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $942.0M. Over the past ten years it has ranged from $311.0M (fiscal 2018) to $2.1B (fiscal 2021); the current reading is higher than 73% of that period. Becton, Dickinson and Company ranks 5th of 54 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $1.7B | (1.58%) |
| FY2024 | $1.7B | 14.89% |
| FY2023 | $1.5B | (16.58%) |
| FY2022 | $1.8B | (14.96%) |
| FY2021 | $2.1B | 139.36% |
| FY2020 | $874.0M | (29.12%) |
| FY2019 | $1.2B | 296.46% |
| FY2018 | $311.0M | (71.73%) |
| FY2017 | $1.1B | 12.70% |
| FY2016 | $976.0M | 40.43% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | $377.0M | — |
| Mar 2026 | −$310.0M | — |
| Dec 2025 | $382.0M | (22.52%) |
| Sep 2025 | $493.0M | (14.11%) |
| 42 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | $3.2B |
| MDLN Medline Inc. compare | $1.9B |
| RMD ResMed Inc. compare | $1.5B |
| SOLV Solventum Corporation compare | $1.4B |
| BDX Becton, Dickinson and Company | $942.0M |
| ALC Alcon compare | $643.0M |
| WST West Pharmaceutical Services, Inc. compare | $564.9M |
| RGEN Repligen Corporation compare | $41.5M |
| BAX Baxter International Inc. compare | −$1.1B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on BDX
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement